Perez-Ruiz F - Search Results

1

Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.

Borghi C, Perez-Ruiz F. Borghi C, et al. Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):983-92. Eur Rev Med Pharmacol Sci. 2016. PMID: 27010159 Free article. Review.

2

Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.

Castrejon I, Toledano E, Rosario MP, Loza E, Pérez-Ruiz F, Carmona L. Castrejon I, et al. Rheumatol Int. 2015 Jul;35(7):1127-37. doi: 10.1007/s00296-014-3189-6. Epub 2014 Dec 18. Rheumatol Int. 2015. PMID: 25519877 Review.

3

Serum uric acid and the risk of cardiovascular and renal disease.

Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Borghi C, et al. J Hypertens. 2015 Sep;33(9):1729-41; discussion 1741. doi: 10.1097/HJH.0000000000000701. J Hypertens. 2015. PMID: 26136207 Review.

4

Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.

Cutolo M, Cimmino MA, Perez-Ruiz F. Cutolo M, et al. Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4186-4195. Eur Rev Med Pharmacol Sci. 2017. PMID: 29028079 Free article.

5

Combination urate-lowering therapy in the treatment of gout: What is the evidence?

Perez-Ruiz F, Dalbeth N. Perez-Ruiz F, et al. Semin Arthritis Rheum. 2019 Feb;48(4):658-668. doi: 10.1016/j.semarthrit.2018.06.004. Epub 2018 Jun 20. Semin Arthritis Rheum. 2019. PMID: 30075988 Review.

6

Gout.

Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, Stamp LK. Dalbeth N, et al. Nat Rev Dis Primers. 2019 Sep 26;5(1):69. doi: 10.1038/s41572-019-0115-y. Nat Rev Dis Primers. 2019. PMID: 31558729 Review.

7

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.

Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Perez-Ruiz F, et al. Arthritis Rheum. 2002 Aug;47(4):356-60. doi: 10.1002/art.10511. Arthritis Rheum. 2002. PMID: 12209479 Free article. Clinical Trial.

8

Gout--what are the treatment options?

Schlesinger N, Dalbeth N, Perez-Ruiz F. Schlesinger N, et al. Expert Opin Pharmacother. 2009 Jun;10(8):1319-28. doi: 10.1517/14656560902950742. Expert Opin Pharmacother. 2009. PMID: 19463070 Review.

9

Evaluation and treatment of gout as a chronic disease.

Perez-Ruiz F, Herrero-Beites AM. Perez-Ruiz F, et al. Adv Ther. 2012 Nov;29(11):935-46. doi: 10.1007/s12325-012-0059-z. Epub 2012 Oct 25. Adv Ther. 2012. PMID: 23104464 Review.

10

Improving cardiovascular and renal outcomes in gout: what should we target?

Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, Punzi L, So AK, Bardin T. Richette P, et al. Nat Rev Rheumatol. 2014 Nov;10(11):654-61. doi: 10.1038/nrrheum.2014.124. Epub 2014 Aug 19. Nat Rev Rheumatol. 2014. PMID: 25136785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters